Oruka Therapeutics (ORKA) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.46
-1.11
-0.75
-0.4

Details

Expected EPS
-0.508333
Actual EPS
-0.4
Surprise EPS
0.11
Surprise Percent
+21.31%

Description

Oruka Therapeutics (ORKA) has reported earnings of -0.4 per share for Q2 2025.

0 Comments

Share your thoughts